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OBJECTIVES In the present study we assessed the distribution and clinical significance of left atrial (LA)
size in the context of athlete’s heart and the differential diagnosis from structural heart disease,
as well as the proclivity to supraventricular arrhythmias.
BACKGROUND The prevalence, clinical significance, and long-term arrhythmic consequences of LA
enlargement in competitive athletes are unresolved.
METHODS We assessed LA dimension and the prevalence of supraventricular tachyarrhythmias in 1,777
competitive athletes (71% of whom were males), free of structural cardiovascular disease, that
were participating in 38 different sports.
RESULTS The LA dimension was 23 to 50 mm (mean, 37  4 mm) in men and 20 to 46 mm (mean,
32 4 mm) in women and was enlarged (i.e., transverse dimension40 mm) in 347 athletes
(20%), including 38 (2%) with marked dilation (45 mm). Of the 1,777 athletes, only 14
(0.8%) had documented, symptomatic episodes of either paroxysmal atrial fibrillation (n  5;
0.3%) or supraventricular tachycardia (n  9; 0.5%), which together occurred in a similar
proportion in athletes with (0.9%) or without (0.8%; p  NS) LA enlargement. Multivariate
regression analysis showed LA enlargement in athletes was largely explained by left
ventricular cavity enlargement (R2  0.53) and participation in dynamic sports (such as
cycling, rowing/canoeing) but minimally by body size.
CONCLUSIONS In a large population of highly trained athletes, enlarged LA dimension 40 mm was
relatively common (20%), with the upper limits of 45 mm in women and 50 mm in men
distinguishing physiologic cardiac remodeling (“athlete’s heart”) from pathologic cardiac
conditions. Atrial fibrillation and other supraventricular tachyarrhythmias proved to be
uncommon (prevalence 1%) and similar to that in the general population, despite the
frequency of LA enlargement. Left atrial remodeling in competitive athletes may be regarded
as a physiologic adaptation to exercise conditioning, largely without adverse clinical
consequences. (J Am Coll Cardiol 2005;46:690–6) © 2005 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.04.052Cardiology Foundation
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(eft atrial (LA) enlargement is an independent predictor of
trial fibrillation in the general population and in patients
ith structural cardiac diseases, such as hypertrophic or
ilated cardiomyopathies (1,2), often conveying adverse
linical consequences (3–6). Several previous investigations
ave suggested that trained athletes are predisposed to
aroxysmal atrial fibrillation, possibly as a consequence of
he cardiac remodeling associated with long-term exercise
raining (7–15). However, the prevalence of LA remodeling
nd the association with supraventricular tachyarrhythmias
ave not yet been systematically addressed in a large
opulation of highly trained athletes.
In the present study involving a large cohort of Italian
lite athletes engaged in a variety of competitive sports, we
ssessed the distribution and clinical significance of LA size
From the *National Institute of Sports Medicine, Italian National Olympic
ommittee, Rome, Italy; †The Hypertrophic Cardiomyopathy Center, Minneapolis
eart Institute Foundation, Minneapolis, Minnesota; and ‡Department of Experi-
ental Medicine, University La Sapienza, Rome, Italy.v
Manuscript received January 20, 2005; revised manuscript received April 1, 2005,
ccepted April 25, 2005.n the context of athlete’s heart and the differential diagnosis
rom structural heart disease, as well as the proclivity to
upraventricular arrhythmias.
ETHODS
election of the study population. All athletes consecu-
ively examined at the National Institute of Sports Medicine
rom 1992 to 1995 initially were considered for inclusion in
he study population. After clinical and echocardiographic
ssessment, 46 showed evidence of structural cardiac abnor-
alities and were excluded from further analysis. Therefore,
he final study population comprised 1,777 highly trained
thletes; of these, 1,566 had been examined as a part of our
edical program for elite athletes (16) and 211 others
nitially had been referred for a suspected cardiovascular
bnormality, which was eventually excluded.
Ages were 24  6 years (range, 11 to 56 years); 1,298
71%) were men. Body surface area was 1.86  0.25 m2
range, 1.15 to 2.38 m2). Athletes participated in a wide
ariety of 38 different sporting disciplines. All were involved
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ime, from 2 to 28 years (mean, 6 years) before their
valuation at our institution. Of the 1,777 athletes, 390
22%) had achieved international recognition in the Olym-
ics or World Championships, and the remaining 1,387
ompeted at the national or regional level. Selected clinical
ata from these athletes have been presented in a previous
eport (17).
chocardiography. Two-dimensional and Doppler echo-
ardiographic studies were performed using a commercially
vailable instrument (Sonos 2500 and 5500, Philips Tech-
ologies, Andover, Massachusetts). Measurements of end-
iastolic and end-systolic left ventricular (LV) cavity dimen-
ions and anterior ventricular septal and posterior free wall
hicknesses were obtained from the M-mode echocardio-
ram, consistent with recommendations of the American
ociety of Echocardiography (18).
Maximum transverse LA dimension was measured from
he M-mode echocardiogram during systole as the average
f three consecutive cycles. Tracings were derived under
irect anatomic visualization from the two-dimensional
chocardiogram in the parasternal long-axis view and re-
orded at 100 mm/s. Because the focus of this study was the
requency with which athletes show LA enlargement in a
ange compatible with pathologic cardiac conditions, we
elied primarily on absolute dimensions (as we have done in
revious echocardiographic surveys of large athlete popula-
ions) (17,19), by selecting a threshold value that has been
onventionally used in large epidemiologic studies (4,5) and
an be placed directly in the context of clinical cardiovas-
ular diagnosis. We chose the arbitrary cutoff of40 mm to
stimate enlarged transverse LA dimension (independent of
ody surface area or gender) because this partition value is
idely used in clinical practice for defining LA enlargement
20).
Left ventricular mass was calculated using the formula
roposed by Devereux (21). Relative wall thickness (h/r)
as the ratio of the average of ventricular septal and
osterior free wall thicknesses to the internal ventricular
avity radius (22). Parameters of LV filling were obtained
ith pulsed Doppler echocardiography, as previously de-
cribed (23).
Echocardiograms were obtained in each athlete during
eriods of intense training; because of unavoidable practical
onsiderations, echocardiography could not always be per-
ormed when athletes were at peak conditioning. When
Abbreviations and Acronyms
ECG  electrocardiogram/electrocardiographic/
electrocardiography
LA  left atrial/atrium
LV  left ventricularerial studies were available from the same athlete, the rchocardiogram obtained at the first evaluation in our
nstitution was used (17,19).
Interobserver variability for measurements of LA dimen-
ion was assessed in a subset of 90 subjects that were
elected randomly from the present study group (and
ncluding 23 athletes with an LA 40 mm). Measurements
ere made independently by two investigators (A.P. and
.J.M.) without knowledge of the identity of the subjects,
nd concordance of measurements from the two observers
as evaluated by intraclass correlation (17,24).
lectrocardiography (ECG). The ECG criteria of LA
nlargement were based on the presence of prolonged
-wave duration of 0.12 s in standard leads I or II and/or
nverted P-wave pattern with terminal negativity of 1 mm
nd 0.04 s in duration in lead V1 (25).
Athletes with symptoms suggestive of supraventricular
achyarrhythmias underwent additional investigation, in-
luding symptom-limited exercise testing, Holter ECG
onitoring (comprising a period of training similar to that
erformed typically by the athlete) and, in selected cases,
lectrophysiologic study (26).
ollow-up of athletes with LA enlargement. Athletes
ith enlarged LA in the absence of cardiac disease, includ-
ng those with supraventricular arrhythmias, were allowed to
ontinue in their training and competition (according to the
talian eligibility guidelines) (27), with the obligation of
eriodic (at least annual) cardiovascular evaluations. In each
f these athletes, clinical status was reassessed in 2003, either
y examination at our institution or by telephone interview.
tatistical methods. Data are expressed as mean  stan-
ard deviation. Differences between mean values were
ssessed with the unpaired Student t test. Differences of
roportions were assessed by the chi-square test. A two-
ailed p  0.05 was considered statistically significant.
Stepwise regression analysis was used to assess the impact
hat several variables (body surface area, age, blood pressure,
eart rate, LV dimensions, LV filling indexes) had on LA
ize; those with statistically significant correlations were
ubsequently incorporated into the covariance analysis, to-
ether with gender and type of sport. Categorical variables
ere coded using a series of (N  1) binary dummy
ariables, and their impact on atrial dimension was assessed
fter removing the effect of the continuous covariates, as
reviously reported (17). The statistical significance of variables
n the covariance analysis was assessed by the Wald test (24).
ESULTS
A dimensions. In the overall population of 1,777 ath-
etes, transverse LA dimension ranged from 22 to 50 mm
mean, 35  4 mm), and was greater in men (23 to 50 mm;
ean, 37  4 mm) than in women (20 to 46 mm; mean, 32
4 mm; p  0.001) (Fig. 1). The vast majority of athletes
i.e., 1,430 [80%]) had normal LA dimension40 mm; the
emaining 347 athletes (20%) showed increased LA size
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Left Atrial Remodeling in Competitive Athletes August 16, 2005:690–640 mm), including 38 (2%) with a markedly dilated LA
45 mm).
ther cardiac dimensions. Left ventricular end-diastolic
avity dimension ranged from 38 to 70 mm (mean, 54  5
m), and exceeded the clinically accepted upper partition
alue (i.e., 55 mm) (28) in a substantial proportion of
thletes (786; 44%), including 251 (14%) with a markedly
ilated LV cavity 60 mm. Maximum LV wall thickness
ventricular septum in each) was 6 to 16 mm (mean, 9  1
m) and exceeded normal limits (i.e., 12 mm) (28) in 17
1%). Left ventricular mass normalized to body surface area
as increased above normal limits (21) in 167 athletes (9%).
eterminants of LA dimension. In the overall group of
,777 athletes, stepwise regression analysis showed that LA
imension was associated with LV end-diastolic cavity
imension (multiple R2  0.53), suggesting that 50% of
ariability in atrial size was due to LV cavity size variability.
y regression analysis, we calculated that in our athletes
ach increase of 1 mm in LV cavity dimension was associ-
ted with a 0.4-mm increase in LA diameter. Other
ariables, including maximum LV wall thickness, body
urface area, and age, showed little additional independent
mpact on LA dimension, together increasing the multiple
2 to 0.58.
Covariance analysis and the Wald test showed that the
ype of sport (as a categorical variable) significantly influ-
nced the variability in LA dimension; specifically, cycling
p  0.05), rowing/canoeing (p  0.05), ice hockey (p 
.01), and rugby (p 0.01) had the largest influence on LA
ize. Gender had no significant additional impact on LA
imension.
revalence of supraventricular tachyarrhythmias. Of the
,777 athletes, 14 (0.8%) had symptomatic and ECG
igure 1. Distribution of transverse left atrium dimensions in 1,777 high
black bars) athletes. Twenty percent of athletes had an enlarged left atriocumented episodes of supraventricular tachyarrhythmias lt the entry of this study, including paroxysmal atrial
brillation (n  5; 0.3%), and supraventricular tachycardia
n  9; 0.5%). None of these arrhythmic episodes were
ssociated with embolic events.
Each of these 14 athletes had experienced prolonged
alpitations either during exercise (n  11) or at rest (n 
), and symptoms were reproduced by occurrence of ar-
hythmia during either 24-h Holter ECG monitoring (n 
), exercise testing or 12-lead ECG (n  1 each), or
nduced at electrophysiologic study (n  6) (Table 1).
thletes with enlarged LAs. DEMOGRAPHICS AND
PORTING DISCIPLINES. The 347 athletes with enlarged
As were predominantly men and had significantly larger
ody surface area compared with the other 1,430 athletes
Table 2). Athletes with enlarged LAs competed in a broad
ariety of 28 different sporting disciplines, with most en-
aged in rowing/canoeing (18%), cycling (10%), ice hockey
10%), rugby, and soccer (7%, each). A larger proportion of
thletes with enlarged LAs had achieved an international
evel of performance and recognition (40% vs. 20% of
thletes with normal-sized LAs; p  0.001).
ARDIAC DIMENSIONS AND FUNCTION. These athletes also
howed greater cardiac dimensional adaptation to training,
ncluding LV end-diastolic cavity 55 mm in 299 (86% vs.
4% in other athletes; p  0.001) and increased LV mass
134 g (27% vs. 5%; p  0.001) (Table 2, Fig. 2) (21).
atterns of transmitral flow-velocity were within normal
imits in each athlete, and none had moderate or severe
itral regurgitation. Left ventricular systolic function was
ormal (i.e., ejection fraction 50%), and segmental wall
otion abnormalities were absent in each (Table 2).
CGS. The 12-lead ECG patterns were within normal
ned athletes. Data are shown separately for female (grey bars) and male
ange, 40 to 50 mm), including 2% with an atrial dimension 45 mm.imits in 117 athletes (34%). The remaining 230 athletes
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August 16, 2005:690–6 Left Atrial Remodeling in Competitive Athletesemonstrated a variety of abnormal patterns, most com-
only increased precordial lead voltages suggestive of LV
ypertrophy (187; 54%), deep narrow Q waves (60; 17%),
nd T-wave inversion (56; 16%). Only 9 of the 347 athletes
3%) with an LA40 mm on an echocardiogram met ECG
riteria for LA enlargement.
UPRAVENTRICULAR TACHYARRHYTHMIAS IN RELATION
O LA DIMENSION. Atrial fibrillation and supraventricular
achycardia, considered together, occurred with similar fre-
uency in athletes with LA enlargement (n  3; 0.9%) and
ith normal sized LAs (n 11; 0.8%; pNS). Paroxysmal
trial fibrillation occurred in only one athlete with enlarged
A and in four athletes with normal LA size (i.e., 0.3%
revalence in both) (Fig. 3). Individual subject analysis of
he 38 athletes with most enlarged LAs of45 mm showed
hat supraventricular tachyarrhythmias were exceedingly
are, occurring in only one of these athletes (Table 1).
able 1. Demographic and Clinical Features of the 14 Athletes W
,777 Highly Trained Athletes
Athlete Gender Age (yrs) Sport P
1 M 23 Rowing Exe
2 M 32 Soccer Res
3 M 16 Volleyball Exe
4 M 20 Rowing Exe
5 M 36 Handball Res
6 M 22 Cross-country skiing Exe
7 M 18 Pentathlon Res
8 F 25 Field hockey Exe
9 M 15 Gymnastics Exe
10 F 28 Basketball Exe
11 M 18 Skating Exe
12 M 23 Skating Exe
13 M 17 Basketball Exe
14 F 28 Basketball Res
Test during which the arrhythmia associated with symptoms was recorded.
AF  paroxysmal atrial fibrillation; AVNRT  atrio-ventricular nodal re-en
lectrocardiogram; EPS  electrophysiologic study; Holter  24-h Holter electroca
Table 2. Clinical, Demographic, and Echocard
Respect to Left Atrial Dimension
Parameter >40
No. athletes 34
Transverse LA dimension 41.7
No. (% male) 339 (
Body surface area (m2) 2.06  0.20
Heart rate (beats/min) 53  10 (
LV end-diastolic dimension (mm) 58.9  3.9 (
Max. LV wall thickness (mm) 10.4  1.1 (
LV mass index (g/m2) 121  21 (
h/r ratio 0.36  0.04
Aorta (mm) 33.5  2.7 (
Emax (mm/s) 68  13 (
Amax (mm/s) 31  9 (1
E/A ratio 2.3  0.8 (
Values are expressed as mean  standard deviation and rang
Amax  peak flow-velocity at late diastole, derived by puby pulsed Doppler; h/r relative wall thickness (ratio of averaged ve
LV cavity radius); LA  left atrium; LV  left ventricular; Max.OLLOW-UP. Of the 347 athletes with an enlarged LA,
linical and echocardiographic data were obtained in 318
92%) during a 1- to 10-year follow-up period (mean, 7 
years). Ages at most recent assessment were 29 to 62 years
mean, 33  6 years). The vast majority of these athletes
i.e., 214, or 61%) had continued in their usual training
chedule and sports competition during the follow-up pe-
iod. Virtually all these athletes (312; 98%) had remained
symptomatic and without evidence of cardiovascular ab-
ormalities during the follow-up. One former basketball
layer, a 33-year-old man, experienced brief episodes of
upraventricular tachycardia without embolic events six
ears after withdrawing from training and competition (i.e.,
.04% year incidence). Of the remaining five athletes, the
hree with a history of atrial fibrillation or supraventricular
achycardia at the entry of this study have continued to
xperience paroxysmal episodes of tachyarrhythmias; two
Supraventricular Tachyarrhythmias Identified Among
tions at Diagnostic Testing* Arrhythmia LA (mm)
EPS AF 38
ECG AF 38
Holter AVRT 32
Holter AVNRT 37
EPS AF 38
EPS AVNRT 40
Holter AF 32
Holter AVNRT 32
Holter AVNRT 36
EPS AVNRT 36
EPS AVRT 33
ECG (during exercise) AVNRT 36
EPS AF 44
Exercise Holter AVNRT 46
tachycardia; AVRT  atrio-ventricular re-entrant tachycardia; ECG  12-lead
phic monitoring; LA  left atrium transverse diameter.
phic Findings in 1,777 Elite Athletes With
LA Dimension
p Value<40 mm
1,430 —
33.9  3.4 —
959 (67%) 0.001
–2.67) 1.81  0.23 (0.98–2.59) 0.001
) 58  11 (31–112) 0.001
0) 52.3  4.9 (38–67) 0.001
) 9.1  1.3 (5–15) 0.001
5) 95  21 (44–170) 0.001
–0.60) 0.35  0.04 (0.23–0.60) 0.004
4) 30.3  3.3 (20–43) 0.001
9) 71  14 (12–123) NS
32  9 (12–108) NS
4.8) 2.4  0.8 (0.4–6.2) NS
arentheses.
oppler; Emax  peak flow-velocity at early diastole, derivedith
alpita
rcise
t
rcise
rcise
t
rcise
t
rcise
rcise
rcise
rcise
rcise
rcise
t plus
trantiogra
mm
7
 2.1
95%)
(1.51
31–94
48–7
7–16
70–19
(0.26
25–4
35–10
5–60)
0.85–
e in p
lsed Dntricular septal and posterior free wall thicknesses to internal
 maximum; NS  not significant.
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Left Atrial Remodeling in Competitive Athletes August 16, 2005:690–6ther athletes died of noncardiac disease (automobile acci-
ent and cancer).
nterobserver variability. Left atrial transverse diameter
easured by the first observer was 36  6 mm (range, 23 to
5 mm) and by the second observer was 36  5 mm (range,
5 to 51 mm). The mean interobserver difference was only
.2 2.1 mm (range 5 to5, mm); p 0.71. Concordance
f measurements from the two observers, as assessed by
ntraclass correlation, was 93%.
ISCUSSION
he present study is relevant to the widespread clinical
erception, based on previous observations in selected ath-
ete groups (8–10,12,14), that lone atrial fibrillation (with
igure 2. Stop-frame two-dimensional parasternal long-axis view (A), M-
ower, showing left atrial enlargement (transverse dimension  45 mm)
imensions; left and right ventricular and right atrial chambers are also en
trium; RV  right ventricle.
igure 3. Prevalence of supraventricular tachyarrhythmias (i.e., paroxysmal
trial fibrillation or supraventricular tachycardia) before or at initial
valuation in our institute with respect to left atrial (LA) dimension, ast
ssessed by echocardiography in 1,777 athletes. AF  paroxysmal atrial
brillation; CV  cardiovascular; SVT  supraventricular tachycardia.he potential for adverse clinical events) occurs dispropor-
ionately in highly trained and professional athletes (29), in
he absence of demonstrable cardiac disease. Left atrial
nlargement in the context of the physiologic cardiac
emodeling in trained athletes (i.e., athlete’s heart) has been
onsidered responsible by itself for a proclivity to atrial
brillation, especially when associated with marked sinus
radycardia (7–9).
The present data shows, however, that LA remodeling
ssociated with intensive exercise and chronic athletic con-
itioning does not predispose per se to supraventricular
achyarrhythmias. In our systematic investigation of more
han 1,700 elite athletes examined during a 3-year period,
trial fibrillation (and other supraventricular tachyarrhyth-
ias) was distinctly uncommon at study entry (0.8%), a
aradoxical finding given the large proportion (i.e., 20%) of
thletes with LA enlargement. Furthermore, these arrhyth-
ias occurred with similar frequency in athletes with
nlarged and with normal LA size. The occurrence of atrial
brillation in only 0.2% of our athlete population closely
esembles the prevalence of paroxysmal atrial fibrillation
i.e., 0.2% to 0.3%) reported in general populations of
omparable age and gender, with or without cardiac disease
30–32).
In addition, only 0.3% of those athletes with an enlarged
A on initial evaluation developed a supraventricular tachy-
ardia during the average seven-year follow-up period (in-
idence 0.04% per year). We cannot exclude, however, the
ossibility that incidence of AF has been underestimated
nd may have been higher if routinely investigated with
CG monitoring (33).
Our data do not support, therefore, the clinical concern
echocardiogram (B), and four-chamber (C) view from a 26-year-old elite
left atrium is globally enlarged in both the transverse and longitudinal
. AO  aortic root; LA  left atrium; LV  left ventricle; RA  rightmode
. Thehat LA enlargement in athletes may predispose them to
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August 16, 2005:690–6 Left Atrial Remodeling in Competitive Athletesdverse clinical sequelae, such as stroke or other embolic
vents (3–5). In contrast to previous studies (7–14), our
bservations show that LA enlargement does not represent
preclinical abnormality in trained athletes but rather likely
epresents an innocent consequence of chronic and intensive
xercise conditioning.
The present data also provide an assessment of LA
imension, with the purpose of defining the upper limits of
trial enlargement associated with intensive athletic training
i.e., athlete’s heart). Recognition of the upper limits of
trial size in competitive athletes is of particular clinical
elevance by offering the opportunity to distinguish physi-
logic and benign cardiac remodeling in athletes from
tructural heart diseases, such as hypertrophic or dilated
ardiomyopathy (2,34). This differential diagnosis has im-
ortant implications because the identification of these
ardiomyopathies often represents the basis, in an effort to
inimize the risk of disease progression or sudden death,
or disqualifying athletes from competition (27,35).
In this regard, our data demonstrate that enlarged LA
ize (40 mm) is relatively common and present in 20% of
large cohort of competitive athletes, including marked
ilatation 45 mm in 2% of our athletes, mimicking the
trial dilatation present in structural cardiac diseases (1,2).
he upper range of LA enlargement in our athlete cohort
as 46 mm in women and 50 mm in men. Therefore,
ransverse LA dimensions exceeding these outer limits in
rained athletes are unlikely to represent the physiologic
onsequences of intensive exercise training and are more
ikely the expression of a primary pathologic condition.
The possible determinants of LA enlargement in our
thlete population remain incompletely resolved. Multivar-
ate regression analysis, however, showed that LA enlarge-
ent occurs in close association with LV cavity enlargement
nd that this morphologic change is minimally related to
ody size and largely dependent on the type of sport
articipated in by the athlete, with cycling, rowing, and
anoeing showing the greatest impact. We have demon-
trated that the same type of sports have the largest effect to
nlarge also LV cavity dimension (17). Our observations
uggest, therefore, that both LA and LV cavity remodeling
bserved in trained athletes represent the physiologic con-
equence of a global cardiac adaptation to the increased
reload associated with intensive and chronic dynamic
raining (17).
This mechanism differs from certain pathologic condi-
ions in which LA enlargement is the consequence of
mpaired LV compliance and/or mitral regurgitation (e.g.,
ypertrophic or dilated cardiomyopathy) (2,34), or in-
reased afterload (e.g., systemic hypertension) (36). Because
ur athletes showed normal LV diastolic filling and systolic
unction, it is reasonable to conclude that their LA enlarge-
ent represents uniquely the physiologic consequence of
hronic exercise training. Finally, ECG was largely ineffi-
ient in detecting LA enlargement because only a small
inority (i.e., 3%) of our athletes with enlarged LAs bychocardiography had ECG criteria that was consistent
ith this diagnosis
onclusions. Atrial fibrillation and other supraventricular
achyarrhythmias proved to be uncommon in our large
opulation of highly trained athletes, despite a relatively
igh prevalence of LA enlargement. Therefore, LA
nlargement in trained athletes can be regarded as a
hysiologic and benign adaptation to exercise condition-
ng and another component of the “athlete’s heart.”
bsolute dimensional cut-offs of 45 mm in women and
0 mm in men may be useful for distinguishing physio-
ogic cardiac remodeling from pathologic conditions such
s cardiomyopathies.
eprint requests and correspondence: Dr. Antonio Pelliccia,
ational Institute of Sports Medicine, Italian National Olympic
ommittee, Via dei Campi Sportivi, 46, 00197 Rome, Italy.
-mail: ant.pelliccia@libero.it.
EFERENCES
1. Olivotto I, Cecchi F, Casey SA, Dolora A, Traverse JH, Maron BJ.
Impact of atrial fibrillation on the clinical course of hypertrophic
cardiomyopathy. Circulation 2001;104:2517–24.
2. Gavazzi A, De Maria R, Renosto G, et al. The spectrum of left
ventricular size in dilated cardiomyopathy: clinical correlates and
prognostic implications. SPIC (Italian Multicenter Cardiomyopathy
Study) Group. Am Heart J 1993;125:410–22.
3. Kopecky SL, Gersh BJ, McGoon MD, et al. The natural history of
lone atrial fibrillation: a population-based study over three decades.
N Engl J Med 1987;317:669–74.
4. Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic
predictors of nonrheumatic atrial fibrillation: the Framingham Heart
Study. Circulation 1994;89:724–30.
5. Benjamin EJ, D’Agostino RB, Belanger AJ, Wolf PA, Levy D. Left
atrial size and the risk of stroke and death: the Framingham Heart
Study. Circulation 1995;92:835–41.
6. Tsang TS, Barnes ME, Bailey KR, et al. Left atrial volume: important
risk marker of incident atrial fibrillation in 1,655 older men and
women. Mayo Clinic Proc 2001;76:467–75.
7. Coumel P. Autonomic influences in atrial tachyarrhythmias. J Car-
diovasc Electrophysiol 1996;7:999–1007.
8. Furlanello F, Bertoldi A, Dallago M, et al. Atrial fibrillation in elite
athletes. J Cardiovasc Electrophysiol 1998;9;S63–8.
9. Link MS, Wang PJ, Estes NA III. Cardiac arrhythmias and electro-
physiologic observations in the athlete. In: Williams R, editor. The
Athlete and Heart Disease. Philadelphia, PA: Lippincott Williams &
Wilkins, 1998:197–216.
0. Jensen-Urstad K. High prevalence of arrhythmias in elderly male
athletes with a lifelong history of regular strenuous exercise. Heart
1998;79:161–4.
1. Estes NA III, Link MS, Cannom D, et al. Report of the NASPE
policy conference on arrhythmias and the athlete. J Cardiovasc
Electrophysiol 2001;12:1208–19.
2. Mont L, Sambola A, Brugada J, et al. Long-lasting sport practice and
lone atrial fibrillation. Eur Heart J 2002;23:477–82.
3. Coumel P. Atrial fibrillation: one more sporting inconvenience? Eur
Heart J 2002;23:431–3.
4. Hoogsteen J, Schep G, van Hemel NM, van der Wall EE. Paroxysmal
atrial fibrillation in male endurance athletes. A 9-year follow up.
Europace 2004;6:222–8.
5. Toutouzas K, Trikas A, Pitsavos C, et al. Echocardiographic features
of left atrium in elite male athletes. Am J Cardiol 1996;78:1314–7.
6. Pelliccia A, Maron BJ. Preparticipation cardiovascular evaluation of
the competitive athlete: perspectives from the 30 year Italian experi-
ence. Am J Cardiol 1995;75:827–8.
11
1
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
696 Pelliccia et al. JACC Vol. 46, No. 4, 2005
Left Atrial Remodeling in Competitive Athletes August 16, 2005:690–67. Pelliccia A, Culasso F, Di Paolo FM, Maron BJ. Physiologic left
ventricular cavity dilatation in elite athletes. Ann Intern Med 1999;
130:23–31.
8. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations
regarding quantitation in M-mode echocardiography: results of a
survey of echocardiographic measurements. Circulation 1978;58:
1072–83.
9. Pelliccia A, Maron BJ, Spataro A, Proschan MA, Spirito P. The upper
limit of physiologic cardiac hypertrophy in highly trained elite athletes.
N Engl J Med 1991;324:295–301.
0. Feigenbaum H. Echocardiography. 4th edition. Philadelphia, PA: Lea
& Febiger; 1986:622.
1. Devereux RB. Detection of left ventricular hypertrophy by M-mode
echocardiography: anatomic validation, standardization, and compar-
ison to other methods. Hypertension 1987;9 Suppl II:19–26.
2. Ford LE. Heart size. Circ Res 1976;39:297–303.
3. Maron BJ, Spirito P, Green KJ, Wesley YE, Bonow RO, Arce J.
Noninvasive assessment of left ventricular diastolic function by pulsed
Doppler echocardiography in patients with hypertrophic cardiomyop-
athy. J Am Coll Cardiol 1987;10:733–42.
4. Armitage P, Berry G. Statistical Methods in Medical Research.
Oxford: McGraw-Hill Publications, 1994:277.
5. Pelliccia A, Maron BJ, Culasso F, et al. Clinical significance of
abnormal electrocardiographic patterns in trained athletes. Circulation
2000;102:278–84.
6. Biffi A, Pelliccia A, Verdile L, et al. Long-term clinical significance of
frequent and complex ventricular tachyarrhythmias in trained athletes.
J Am Coll Cardiol 2002;40:446–52.7. Organizing Cardiologic Committee on Eligibility for Sports (COCIS).
Cardiologic Protocols on Determining Eligibility for Competitive Sports.
Rome: CESI Publisher, 2003:1–114.
8. Henry WL, Gardin JM, Ware JH. Echocardiographic measurements
in normal subjects from infancy to old age. Circulation 1980;62:1054–
61.
9. “Atrial fibrillation” search query at home page of the National
Basketball Association. Available at: www.nba.com. Accessed June 22,
2005.
0. Rose G, Baxter PJ, Reid DD, McCartney P. Prevalence and prognosis
of electrocardiographic findings in middle-aged men. Br Heart J
1978;40:636–43.
1. Halperin JL, Hart RG. Atrial fibrillation and stroke: new ideas,
persisting dilemmas. Stroke 1988;19:937–41.
2. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic
features of chronic atrial fibrillation. The Framingham Study. N Engl
J Med 1982;306:1018–22.
3. Fetsch T, Bauer P, Engberding R, et al. Prevention of atrial fibrillation
after cardioversion: results of the PAFAC study. Eur Heart J 2004;
25:1385–94.
4. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA
2002;287:1308–20.
5. Maron BJ, Zipes DP. 36th Bethesda Conference: eligibility recom-
mendations for competitive athletes with cardiovascular abnormalities.
J Am Coll Cardiol 2005;45:2–64.
6. Ganau A, Devereux RB, Roman MJ, et al. Patterns of left ventricular
hypertrophy and geometric remodeling in essential hypertension. J Am
Coll Cardiol 1992;19:1550–8.
